| Name | Title | Contact Details |
|---|---|---|
Gavin Ge |
Head of Human Resource and Admin | Profile |
Johny Zhang |
Co Founder and Chief Executive Officer | Profile |
BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime`s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime`s lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX.
Antibody Solutions is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tanox, Inc. is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Southern Biotech Associates is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
At Vyriad, we are developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.